Chymotrypsin

DB09375ApprovedInvestigationalVet approvedWithdrawnProtein Based Therapies

Chymotrypsin is a digestive enzyme supplement used as supportive therapy to manage the side effects associated with conventional chemotherapy, radiotherapy, and hormone therapy. Chymotrypsin (EC 3.4.21.1) is a digestive enzyme that promotes proteolysis, or the breakdown of proteins and polypeptides.

Mechanism
Curator reviewed · 3 references
Primary indication
No therapeutic indications.Curator reviewed · 6 structured indications
First approval
Canada, 1988
Also known as
alpha-Chymotrypsin · Chymotrypsin A · Chymotrypsin B

Resolves to

What you can answer from here — as of May 29, 2025

1Drug interactionStructured to mechanism, not free text
Sign in
10Clinical trialsPhase, status and sponsor resolved per trial
Sign in
6Structured indicationsCondition, population, route and combination as fields, not prose
Sign in
12ContraindicationsEach with its own population and attribute set
Sign in
3Marketed productsAcross 2 countries and 2 labellers
Sign in
2ATC codesIncluding every combination product, plus 11 drug categories
Sign in
3+ReferencesStructured and connected to the statements they support
Sign in

Which other approved drugs treat the same conditions as Chymotrypsin, and which companies have late-stage candidates in those indications?

Create a free account or log in to explore the full data card.

Create Account